Literature DB >> 12169217

Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.

Karen Marder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12169217     DOI： 10.1007/s11910-002-0063-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  15 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R S Doody; J C Stevens; C Beck; R M Dubinsky; J A Kaye; L Gwyther; R C Mohs; L J Thal; P J Whitehouse; S T DeKosky; J L Cummings
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

3.  A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

Authors:  P L Le Bars; M M Katz; N Berman; T M Itil; A M Freedman; A F Schatzberg
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

4.  Dementia in idiopathic Parkinson's disease: prevalence and relationship with symptoms and signs of parkinsonism.

Authors:  K P Ebmeier; S A Calder; J R Crawford; L Stewart; R H Cochrane; J A Besson
Journal:  Psychol Med       Date:  1991-02       Impact factor: 7.723

5.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Authors:  I McKeith; T Del Ser; P Spano; M Emre; K Wesnes; R Anand; A Cicin-Sain; R Ferrara; R Spiegel
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

6.  European Pentoxifylline Multi-Infarct Dementia Study.

Authors: 
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

7.  A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

Authors:  P N Tariot; P R Solomon; J C Morris; P Kershaw; S Lilienfeld; C Ding
Journal:  Neurology       Date:  2000-06-27       Impact factor: 9.910

8.  The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.

Authors:  M C van Dongen; E van Rossum; A G Kessels; H J Sielhorst; P G Knipschild
Journal:  J Am Geriatr Soc       Date:  2000-10       Impact factor: 5.562

9.  Pentoxifylline in cerebrovascular dementia.

Authors:  R S Black; L L Barclay; K A Nolan; H T Thaler; S T Hardiman; J P Blass
Journal:  J Am Geriatr Soc       Date:  1992-03       Impact factor: 5.562

10.  Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals.

Authors:  F Tison; J F Dartigues; S Auriacombe; L Letenneur; F Boller; A Alpérovitch
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.